A Elgamal
Overview
Explore the profile of A Elgamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
172
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mousa N, Abdel-Razik A, Sheta T, G Deiab A, Habib A, Diasty M, et al.
Br J Biomed Sci
. 2020 Dec;
78(3):130-134.
PMID: 33305686
Acute oesophageal variceal haemorrhage (AOVH) is a medical emergency. The American Association for the Study of Liver Diseases recommends endoscopy management as soon as possible and not more than 12...
2.
Elbaz S, Mousa N, Besheer T, Sheta T, Taha K, Awad M, et al.
Br J Biomed Sci
. 2020 Jan;
77(2):94-96.
PMID: 31971480
No abstract available.
3.
Mousa N, Abdel-Razik A, Sheta T, Shabana W, Zakaria S, Awad M, et al.
Br J Biomed Sci
. 2018 Aug;
75(4):192-196.
PMID: 30079841
Background: The relationship between hepatitis B virus (HBV) infection, leptin and insulin resistance remains unclear. We hypothesised links between serum leptin and insulin resistance in non-diabetic patients with chronic viral...
4.
Wadhera S, Khetan M, Bhatia P, John S, Bindal V, Matyja A, et al.
Hernia
. 2015 Nov;
19 Suppl 1:S93-7.
PMID: 26518868
No abstract available.
5.
Murphy G, Snow P, Brandt J, Elgamal A, Brawer M
Prostate
. 2000 Jan;
42(2):145-9.
PMID: 10617872
Background: Multiple serum tests were performed on archival samples from patients who participated in trials to assess the ProstaScint scan staging ability. Traditional statistical analysis as well as artificial neural...
6.
Awaad Y, Tayem H, Elgamal A, Coyne M
J Child Neurol
. 1999 Dec;
14(12):781-6.
PMID: 10614564
Because of inadequate response to or intolerable side effects of oral medication, nine patients with segmental, generalized, and focal myoclonus were treated with intramuscular botulinum toxin type A. All patients...
7.
Tjoa B, Simmons S, Elgamal A, Rogers M, RAGDE H, Kenny G, et al.
Prostate
. 1999 Jul;
40(2):125-9.
PMID: 10386473
Background: A phase II trial, involving infusions of autologous dendritic cells (DC) and two human histocompatibility antigen (HLA-A2)-specific prostate-specific membrane antigen (PSMA) peptides, was recently completed. Thirty percent of the...
8.
Simmons S, Tjoa B, Rogers M, Elgamal A, Kenny G, RAGDE H, et al.
Prostate
. 1999 May;
39(4):291-7.
PMID: 10344219
Background: Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF; Leukine [sargramostim], Immunex Corp., Seattle, WA) was administered to a subgroup of 44 patients in a phase II clinical trial for prostate cancer...
9.
Murphy G, Tjoa B, Simmons S, RAGDE H, Rogers M, Elgamal A, et al.
Prostate
. 1999 Apr;
39(1):54-9.
PMID: 10221267
Background: A phase II trial was conducted to assess the efficacy of infusions of dendritic cells (DC) and two HLA-A2-specific prostate-specific membrane antigen (PSMA) peptides (PSM-P1 and -P2). This report...
10.
Murphy G, Tjoa B, Simmons S, Jarisch J, Bowes V, RAGDE H, et al.
Prostate
. 1999 Feb;
38(1):73-8.
PMID: 9973112
Background: A phase II trial was conducted to assess the efficacy of infusions of dendritic cells (DC) and two HLA-A2-specific PSMA peptides (PSM-P1 and -P2). This report describes thirty three...